Biopharma Embraces Synthetic Biology
Applying new tools from cell engineering to compact CRISPR and drug design.
By Tiffany Yesavage, PhD
Synthetic biology—an emerging and often debated field—involves the application of engineering principles to biological systems.
The European Commission today defines synthetic biology as the use of science, technology, and engineering to facilitate “the design, manufacture, and/or modification of genetic materials in living organisms.”
Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, it has begun to drive innovation in biopharmaceuticals.
Author summary: Biopharma innovates with synthetic biology tools.
More News
- A Day in the Life of Marian O'Gorman, CEO of Kilkenny Group
- Queenslands Energy Roadmap is more likely to be first steps than a completed journey - On Line Opinion - 30/10/2025
- Steve García demolishes a lifeless David Onama with a first-round finish at UFC Vegas 110
- An Instant Classic, the 2025 World Series Was a Huge Win for MLB
- Dodgers Cement Dynasty with Back-to-Back World Series Wins
- Measuring what is important: Evaluating board effectiveness
- Andy Cohen Praises a Dallas Church for its Reponse to Gov. Abbott's War on Crosswalks